FHLW

Check out the new Faith-Love-Hope-Win website, http://www.flhw.org . FLHW is a non-profit organization that raises money to fight advanced prostate cancer. They deserve the support of the prostate cancer community (hint: order some blue bracelets from them!)

Few Side Effects Found From Radiation Treatment Given After Prostate Cancer Surgery

ScienceDaily (2009-09-29) -- The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a prostate-specific antigen test following surgery indicated their cancer had recurred.

http://www.sciencedaily.com/releases/2009/09/090928131212.htm#

Larry King

If you missed last night's Larry King Live, here is a transcript:
http://transcripts.cnn.com/TRANSCRIPTS/0908/21/lkl.01.html
The whole show was about prostate cancer.

Proton Cancer Therapy Accelerates

Interesting news story on CBS.com

"...new research being developed at Lawrence Livermore National Laboratory, which could reduce the size of proton accelerator machines from that of a football field to that of a traditional X-ray machine, could soon make proton therapy more easily accessible to all."

off topic: cool music video

Stand By Me from Mike Yates on Vimeo.

How to Estimate Your Prostate Cancer Cure Odds

I've just written an article on eHow that summarizes the tools (nomograms, tables, etc) that help you predict how far prostate cancer has spread, and the likelihood of successful primary treatment. "How to Estimate Your Prostate Cancer Cure Odds"

Lack of volunteers impedes cancer research

An important article from the New York Times, a paper that should be commended for its excellent coverage of cancer over the past few years.

Forty Years' War - Lack of Study Volunteers Hobbles Cancer Fight

Excerpt:

There are more than 6,500 cancer clinical trials seeking adult patients, according to clinicaltrials.gov, a trials registry. But many will be abandoned along the way. More than one trial in five sponsored by the National Cancer Institute failed to enroll a single subject, and only half reached the minimum needed for a meaningful result, Dr. Ramsey and his colleague John Scoggins reported in an editorial in the September 2008 issue of The Oncologist.